Imalliance (XPAR:MLIML) Research & Development: €0.00 Mil (TTM As of Dec. 2024)


XPAR:MLIML Imalliance SA XPAR:MLIML
31 GF Score
Price €0.23
GF Value €0.27
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imalliance Research & Development?

Imalliance XPAR:MLIML 31 Research & Development is €0.00 Mil as of Dec. 2024. GuruFocus rates XPAR:MLIML with a GF Score™ of 31/100 and a GF Value™ of €0.27 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Imalliance's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Imalliance  (XPAR:MLIML) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Imalliance Research & Development Related Terms

Imalliance Research & Development Historical Data

* Premium members only.

The historical data trend for Imalliance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imalliance Research & Development Chart

Imalliance Annual Data
Trend Dec15 Dec16 Dec17 Dec23 Dec24
Research & Development
0.00 0.00 0.00 0.00 0.00

Imalliance Semi-Annual Data
Dec15 Dec16 Dec17 Dec23 Dec24
Research & Development 0.00 0.00 0.00 0.00 0.00
XPAR:MLIML
31GF Score
Imalliance SA XPAR:MLIML
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imalliance Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Imalliance (XPAR:MLIML) has a Research & Development of €0.00 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Imalliance and its competitors.
Is Imalliance's Research & Development too high?
Imalliance's current Research & Development is €0.00 Mil. Overall, Imalliance has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imalliance's Research & Development compare to NYT and WLY?
Imalliance's Research & Development of €0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Imalliance and its competitors. Imalliance's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imalliance stock overvalued right now?
Based on GuruFocus' analysis, Imalliance (XPAR:MLIML) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.27, compared to a current price of €0.23 — trading 14.1% below its estimated fair value. The current Research & Development is €0.00 Mil. Imalliance's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Imalliance (XPAR:MLIML), the current Research & Development is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imalliance (XPAR:MLIML) Overvalued in 2026?

Based on GuruFocus' analysis, Imalliance stock appears to be undervalued. The current stock price of €0.23 is trading 14.1% below its estimated GF Value™ of €0.27. GuruFocus considers Imalliance to be Modestly Undervalued.

Key valuation signals for XPAR:MLIML:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.27 vs. price of €0.23 (14.1% below fair value)
  • GF Score™: 31/100 with 2 warning signs

No single metric tells the full story. See the XPAR:MLIML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imalliance Business Description

Address 5 rue Paul Bert, Cap St-Ouen, Saint-Ouen, FRA, 94300
Imalliance SA specializes in editing and publishing catalogs, annual reports, training materials, press releases, newspapers, books, and other advertising documents. The company acts as a platform for content production and multi-format creation in the photo, web, and video fields.
31GF Score

Get the complete analysis for XPAR:MLIML

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23
Price
€0.27
GF Value